Bladder cancer

UPDATED --- New hope for patients progressing after prior treatment for mUCa

Last updated: 01.10.2024

Solve cases and receive feedback

Case 1 - Progression after 1st-line chemotherapy
Case 2 - Progression on maintenance nivolumab
Case 3 - Progression on 2nd-line immunotherapy
Case 4 - Progression on 1st-line enfortumab vedotin + pembrolizumab
Case 5 - Progression after 1st-line chemotherapy, CDK
Case 6 - Progression on maintenance avelumab
Case 7 - Progression on 1st-line immunotherapy

Follow a course and earn CME credits

Earn CME credits by running a case series and completing an assessment. Many topics available for various disease areas. And all for free!

Start a course